Noven To Present At Deutsche Bank Health Care Conference

-- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that Robert C. Strauss, its President, CEO & Chairman, is scheduled to provide an update on Noven’s business and prospects on Monday, May 2, 2005 at 1:30 p.m. Eastern Time at the Deutsche Bank 30th Annual Health Care Conference in Baltimore. A live webcast of the presentation will be accessible to the public at www.noven.com and a rebroadcast will be available thereafter at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Alina Bowman
Investor Relations Coordinator
305-253-1916